UM

Browse/Search Results:  1-2 of 2 Help

Selected(0)Clear Items/Page:    Sort:
Involvement of Bile Acid Metabolism and Gut Microbiota in the Amelioration of Experimental Metabolism-Associated Fatty Liver Disease by Nobiletin Journal article
Xu, Hongling, Yuan, Mingming, Niu, Kailin, Yang, Wei, Jiang, Maoyuan, Zhang, Lei, Zhou, Jing. Involvement of Bile Acid Metabolism and Gut Microbiota in the Amelioration of Experimental Metabolism-Associated Fatty Liver Disease by Nobiletin[J]. Molecules, 2024, 29(5), 976.
Authors:  Xu, Hongling;  Yuan, Mingming;  Niu, Kailin;  Yang, Wei;  Jiang, Maoyuan; et al.
Favorite | TC[WOS]:1 TC[Scopus]:1  IF:4.2/4.6 | Submit date:2024/04/02
Nobiletin  Bile Acid  Gut Microbiota  Farnesoid x Receptor  Metabolism-associated Fatty Liver Disease  
Intravital lipid droplet labeling and imaging reveals the phenotypes and functions of individual macrophages in vivo Journal article
Li, Yue, Du, Yuwei, Xu, Zhengqing, He, Yuan, Yao, Ran, Jiang, Huiran, Ju, Wen, Qiao, Jianlin, Xu, Kailin, Liu, Tzu Ming, Zeng, Lingyu. Intravital lipid droplet labeling and imaging reveals the phenotypes and functions of individual macrophages in vivo[J]. Journal of lipid research, 2022, 63(5), 100207.
Authors:  Li, Yue;  Du, Yuwei;  Xu, Zhengqing;  He, Yuan;  Yao, Ran; et al.
Adobe PDF | Favorite | TC[WOS]:6 TC[Scopus]:8  IF:5.0/5.7 | Submit date:2022/08/02
Biomarker  Bone Marrow  Fatty Acid Analog  Inflammation  In vivo Imaging  Lipid Droplet  Lipid Trafficking  Macrophage  Nanoparticle Delivery  Systemic Inflammation